大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/10 | 1,612 | 1,644 | 1,604 | 1,620 | +18 | +1.1% | 593,000 |
2020/12/09 | 1,611 | 1,617 | 1,595 | 1,602 | -9 | -0.6% | 487,300 |
2020/12/08 | 1,600 | 1,619 | 1,575 | 1,611 | -2 | -0.1% | 595,600 |
2020/12/07 | 1,643 | 1,651 | 1,606 | 1,613 | -20 | -1.2% | 575,000 |
2020/12/04 | 1,630 | 1,640 | 1,595 | 1,633 | -8 | -0.5% | 875,700 |
2020/12/03 | 1,660 | 1,660 | 1,630 | 1,641 | -25 | -1.5% | 746,400 |
2020/12/02 | 1,710 | 1,722 | 1,650 | 1,666 | -44 | -2.6% | 1,023,400 |
2020/12/01 | 1,698 | 1,732 | 1,691 | 1,710 | +25 | +1.5% | 700,100 |
2020/11/30 | 1,710 | 1,723 | 1,675 | 1,685 | -3 | -0.2% | 756,700 |
2020/11/27 | 1,683 | 1,710 | 1,666 | 1,688 | +4 | +0.2% | 696,800 |
2020/11/26 | 1,665 | 1,695 | 1,652 | 1,684 | +7 | +0.4% | 649,300 |
2020/11/25 | 1,708 | 1,724 | 1,662 | 1,677 | -48 | -2.8% | 1,090,900 |
2020/11/24 | 1,699 | 1,744 | 1,672 | 1,725 | -6 | -0.3% | 1,411,800 |
2020/11/20 | 1,799 | 1,810 | 1,705 | 1,731 | -17 | -1% | 1,471,700 |
2020/11/19 | 1,683 | 1,780 | 1,680 | 1,748 | +113 | +6.9% | 2,596,200 |
2020/11/18 | 1,615 | 1,684 | 1,608 | 1,635 | -11 | -0.7% | 1,524,200 |
2020/11/17 | 1,710 | 1,710 | 1,605 | 1,646 | -116 | -6.6% | 2,066,300 |
2020/11/16 | 1,796 | 1,826 | 1,745 | 1,762 | -21 | -1.2% | 1,150,600 |
2020/11/13 | 1,864 | 1,873 | 1,706 | 1,783 | -130 | -6.8% | 3,059,000 |
2020/11/12 | 1,937 | 1,958 | 1,866 | 1,913 | +14 | +0.7% | 1,433,100 |
2020/11/11 | 1,849 | 1,921 | 1,838 | 1,899 | +73 | +4% | 1,250,900 |
2020/11/10 | 2,004 | 2,008 | 1,801 | 1,826 | -180 | -9% | 1,977,500 |
2020/11/09 | 1,994 | 2,029 | 1,962 | 2,006 | +31 | +1.6% | 972,000 |
2020/11/06 | 2,003 | 2,006 | 1,955 | 1,975 | -16 | -0.8% | 859,600 |
2020/11/05 | 1,998 | 2,012 | 1,946 | 1,991 | +29 | +1.5% | 1,345,100 |
2020/11/04 | 1,920 | 1,966 | 1,906 | 1,962 | +64 | +3.4% | 928,600 |
2020/11/02 | 1,878 | 1,915 | 1,877 | 1,898 | +28 | +1.5% | 558,400 |
2020/10/30 | 1,906 | 1,930 | 1,858 | 1,870 | -30 | -1.6% | 990,000 |
2020/10/29 | 1,849 | 1,917 | 1,837 | 1,900 | +26 | +1.4% | 730,900 |
2020/10/28 | 1,879 | 1,923 | 1,837 | 1,874 | -14 | -0.7% | 777,800 |
2020/10/27 | 1,829 | 1,888 | 1,801 | 1,888 | +29 | +1.6% | 559,100 |
2020/10/26 | 1,891 | 1,896 | 1,849 | 1,859 | -19 | -1% | 540,100 |
2020/10/23 | 1,873 | 1,885 | 1,827 | 1,878 | -12 | -0.6% | 712,200 |
2020/10/22 | 1,917 | 1,917 | 1,858 | 1,890 | -53 | -2.7% | 966,200 |
2020/10/21 | 1,940 | 1,959 | 1,926 | 1,943 | -17 | -0.9% | 524,100 |
2020/10/20 | 1,966 | 1,972 | 1,931 | 1,960 | -31 | -1.6% | 674,300 |
2020/10/19 | 1,979 | 2,008 | 1,954 | 1,991 | +19 | +1% | 584,600 |
2020/10/16 | 2,130 | 2,160 | 1,935 | 1,972 | -38 | -1.9% | 2,253,900 |
2020/10/15 | 2,027 | 2,034 | 1,993 | 2,010 | -40 | -2% | 654,900 |
2020/10/14 | 2,058 | 2,074 | 2,026 | 2,050 | -26 | -1.3% | 579,500 |
2020/10/13 | 2,119 | 2,121 | 2,055 | 2,076 | -52 | -2.4% | 733,800 |
2020/10/12 | 2,136 | 2,166 | 2,106 | 2,128 | +3 | +0.1% | 607,100 |
2020/10/09 | 2,103 | 2,139 | 2,088 | 2,125 | ±0 | ±0% | 561,000 |
2020/10/08 | 2,138 | 2,141 | 2,065 | 2,125 | -34 | -1.6% | 1,530,800 |
2020/10/07 | 2,195 | 2,199 | 2,135 | 2,159 | -49 | -2.2% | 871,000 |
2020/10/06 | 2,175 | 2,220 | 2,164 | 2,208 | +14 | +0.6% | 686,600 |
2020/10/05 | 2,188 | 2,204 | 2,158 | 2,194 | -2 | -0.1% | 590,000 |
2020/10/02 | 2,251 | 2,251 | 2,168 | 2,196 | - | - | 972,200 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,294 | 2,306 | 2,247 | 2,252 | -21 | -0.9% | 606,900 |
1151~
1200
件表示中 / 4021件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム